BACKGROUND. The human bone marrow (BM) niche contains a population of mesenchymal stromal cells (MSCs) that provide physical support and regulate hematopoietic stem cell (HSC) homeostasis. β-Thalassemia (BT) is a hereditary disorder characterized by altered hemoglobin beta-chain synthesis amenable to allogeneic HSC transplantation and HSC gene therapy. Iron overload (IO) is a common complication in BT patients affecting several organs. However, data on the BM stromal compartment are scarce. METHODS. MSCs were isolated and characterized from BM aspirates of healthy donors (HDs) and BT patients. The state of IO was assessed and correlated with the presence of primitive MSCs in vitro and in vivo. Hematopoietic supportive capacity of MSCs was evaluated by transwell migration assay and 2D coculture of MSCs with human CD34+ HSCs. In vivo, the ability of MSCs to facilitate HSC engraftment was tested in a xenogenic transplant model, whereas the capacity to sustain human hematopoiesis was evaluated in humanized ossicle models. RESULTS. We report that, despite iron chelation, BT BM contains high levels of iron and ferritin, indicative of iron accumulation in the BM niche. We found a pauperization of the most primitive MSC pool caused by increased ROS production in vitro which impaired MSC stemness properties. We confirmed a reduced frequency of primitive MSCs in vivo in BT patients. We also discovered a weakened antioxidative response and diminished expression of BM niche–associated genes in BT-MSCs. This caused a functional impairment in MSC hematopoietic supportive capacity in vitro and in cotransplantation models. In addition, BT-MSCs failed to form a proper BM niche in humanized ossicle models. CONCLUSION. Our results suggest an impairment in the mesenchymal compartment of BT BM niche and highlight the need for novel strategies to target the niche to reduce IO and oxidative stress before transplantation. FUNDING. This work was supported by the SR-TIGET Core grant from Fondazione Telethon and by Ricerca Corrente.
Stefania Crippa, Valeria Rossella, Annamaria Aprile, Laura Silvestri, Silvia Rivis, Samantha Scaramuzza, Stefania Pirroni, Maria Antonietta Avanzini, Luca Basso-Ricci, Raisa Jofra Hernandez, Marco Zecca, Sarah Marktel, Fabio Ciceri, Alessandro Aiuti, Giuliana Ferrari, Maria Ester Bernardo
Title and authors | Publication | Year |
---|---|---|
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities
Bulté D, Barzaghi F, Mesa-Nuñez C, Rigamonti C, Basso-Ricci L, Visconti C, Crippa S, Pettinato E, Gilioli D, Milani R, Quaranta P, Caorsi R, Cafaro A, Cangemi G, Lupia M, Schena F, Grossi A, Di Colo G, Federici S, Insalaco A, De Benedetti F, Marktel S, Di Micco R, Bernardo ME, Scala S, Cicalese MP, Conti F, Miano M, Gattorno M, Dufour C, Aiuti A, Mortellaro A |
The Journal of Allergy and Clinical Immunology | 2025 |
Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives
Li Z, Yao X, Zhang J, Yang J, Ni J, Wang Y |
Frontiers in Immunology | 2024 |
Long-term lineage commitment in haematopoietic stem cell gene therapy
Calabria A, Spinozzi G, Cesana D, Buscaroli E, Benedicenti F, Pais G, Gazzo F, Scala S, Lidonnici MR, Scaramuzza S, Albertini A, Esposito S, Tucci F, Canarutto D, Omrani M, De Mattia F, Dionisio F, Giannelli S, Marktel S, Fumagalli F, Calbi V, Cenciarelli S, Ferrua F, Gentner B, Caravagna G, Ciceri F, Naldini L, Ferrari G, Aiuti A, Montini E |
Nature | 2024 |
Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome
Katzerke C, Schaffrath J, Lützkendorf J, Janssen M, Merbach AK, Nerger K, Binder M, Baum C, Lauer K, Rohde C, Willscher E, Müller-Tidow C, Müller LP |
Blood Advances | 2023 |
The influence of iron on bone metabolism disorders.
Zhang H, Yang F, Cao Z, Xu Y, Wang M |
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2023 |
Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients
L Ding, D Han, H Yan, J Zhou, X Zheng, L Zhu, M Xue, J Liu, N Mao, Z Guo, H Ning, H Wang, H Zhu |
Bone Marrow Transplantation | 2022 |
The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation
W Fibbe, R Bernardi, P Charbord, D Krause, C Celso, S Méndez-Ferrer, C Mummery, R Oostendorp, M Raaijmakers, G Socié, F Staal, A Bacigalupo |
HemaSphere | 2022 |
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.
Aprile A, Sighinolfi S, Raggi L, Ferrari G |
Pharmaceuticals (Basel, Switzerland) | 2022 |
Extracellular Hemoglobin: Modulation of Cellular Functions and Pathophysiological Effects.
Drvenica IT, Stančić AZ, Maslovarić IS, Trivanović DI, Ilić VL |
Biomolecules | 2022 |
Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease
A Tang, AN Strat, M Rahman, H Zhang, W Bao, Y Liu, D Shi, X An, D Manwani, P Shi, K Yazdanbakhsh, A Mendelson |
Blood | 2021 |
Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome
S Crippa, L Santi, M Berti, GD Ponti, ME Bernardo |
Frontiers in Cell and Developmental Biology | 2021 |
Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs
F Longo, A Piolatto, GB Ferrero, A Piga |
International journal of molecular sciences | 2021 |
Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy
TO Rosanwo, DE Bauer |
Molecular Therapy | 2021 |
Identifying the functions of two biomarkers in human oligodendrocyte progenitor cell development
H Zhou, Y He, Z Wang, Q Wang, C Hu, X Wang, S Lu, K Li, Y Yang, Z Luan |
Journal of Translational Medicine | 2021 |
Extracellular Vesicle MicroRNA That Are Involved in β-Thalassemia Complications
C Levin, A Koren, A Rebibo-Sabbah, M Levin, N Koifman, B Brenner, A Aharon |
International journal of molecular sciences | 2021 |
The EHA Research Roadmap: Normal Hematopoiesis
T Jaffredo, A Balduini, A Bigas, R Bernardi, D Bonnet, B Canque, P Charbord, A Cumano, R Delwel, C Durand, W Fibbe, L Forrester, L de Franceschi, C Ghevaert, B Gjertsen, B Gottgens, T Graf, O Heidenreich, O Hermine, D Higgs, M Kleanthous, H Klump, V Kouskoff, D Krause, G Lacaud, CL Celso, JH Martens, S Méndez-Ferrer, P Menendez, R Oostendorp, S Philipsen, B Porse, M Raaijmakers, C Robin, H Stunnenberg, K Theilgaard-Mönch, I Touw, W Vainchenker, JL Corrons, L Yvernogeau, JJ Schuringa |
HemaSphere | 2021 |
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development National Institutes of Health/Bill & Melinda Gates Foundation Expert Scientific Roundtable Webinar Meeting
P Cannon, A Asokan, A Czechowicz, P Hammond, D Kohn, A Lieber, P Malik, P Marks, M Porteus, E Verhoeyen, D Weissman, I Weissman, H Kiem |
Human Gene Therapy | 2021 |
Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major
P Fianza, A Rahmawati, S Afifah, S Praptama, M Ghozali, T Sihite, D Setiabudi, M Syamsunarno, S Fucharoen, R Panigoro, H Zhou |
Disease Markers | 2021 |
Update on Clinical Ex Vivo Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic Diseases
F Tucci, S Scaramuzza, A Aiuti, A Mortellaro |
Molecular Therapy | 2020 |
Gene therapy using haematopoietic stem and progenitor cells
G Ferrari, AJ Thrasher, A Aiuti |
Nature Reviews Genetics | 2020 |
Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche
A Aprile, A Gulino, M Storto, I Villa, S Beretta, I Merelli, A Rubinacci, M Ponzoni, S Marktel, C Tripodo, MR Lidonnici, G Ferrari |
Blood | 2020 |
Targeting the bone marrow niche in hemoglobinopathies
N Carlesso |
Blood | 2020 |
AMD3100 re-dosing fails to repeatedly mobilize hematopoietic stem cells in the non-human primate and humanized mouse
C Samuelson, S Radtke, M Cui, A Perez, HP Kiem, O Humbert |
Experimental Hematology | 2020 |
The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases
Z Kuҫi, C Jordan, S Wehner, J Sörensen, A Jarisch, E Salzmann-Manrique, LM Pfeffermann, T Klingebiel, P Bader, S Kuҫi |
Cells | 2020 |
Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders
E Tibaldi, E Federti, A Matte, I Iatcenko, AB Wilson, V Riccardi, MA Pagano, LD Franceschi |
Antioxidants | 2020 |
Challenging the Erythropoiesis Paradigm in β-Thalassemia
F Vinchi, SZ Vance |
HemaSphere | 2020 |
[Effect of cyclophosphamide on hematopoietic stem cells in mice with iron overload]
Yanjun Xu, Tiantian Yi, Xiaoxiao Xu, Fuyu Pei, Yuelin He, Xuedong Wu |
Nan fang yi ke da xue xue bao = Journal of Southern Medical University | 2020 |
Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives
FJ Staal, A Aiuti, M Cavazzana |
Frontiers in Pediatrics | 2019 |
Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders
S Crippa, L Santi, R Bosotti, G Porro, ME Bernardo |
Journal of Clinical Medicine | 2019 |